India's Healthcare Sector Draws Record Private Equity Investment in 2024
Wednesday, 23 April 2025, 19:27 IST
In 2024, India has emerged as the leading private equity (PE) market in the Asia-Pacific healthcare sector, accounting for 26% of the region's total deal volume, as reported by Bain & Company. This achievement highlights India's growing prominence in the global healthcare investment landscape.
While the broader Asia-Pacific region experienced a significant downturn in buyout activity, with a nearly 49% decline, India managed to weather the storm with only an 18% decrease in healthcare private equity deals compared to 2023. Bain & Company’s report indicates that India has solidified its position as the dominant player in the region, capturing a substantial share of healthcare deal volume. Investors are recognizing that India’s health sector is not just holding steady; it is flourishing.
Key Factors Fueling the Growth
What factors are contributing to India’s robust performance in healthcare investments?
Strong Economic Growth: With a projected GDP growth rate of 7% in 2024, India’s economy is fostering a strong appetite for investment.
Successful Exits: The $1.6 billion sale of BSV Group to Mankind Pharma by Advent International exemplifies a successful exit, showcasing the potential for lucrative returns in the sector.
Rising Healthcare Spending: Forecasts suggest that healthcare expenditure will soar to $320 billion by 2028, signaling a lucrative opportunity for investors.
Investment Trends
In recent years, investor interest has concentrated on hospitals, clinics, and support services, with biopharma deals also gaining traction. However, healthcare providers healthcare providers have been the focal point of activity. The increasing demand for quality healthcare in India is driving a surge in deal-making, prompting private equity firms to actively seek investment opportunities.
Outlook
With a strong economic foundation and a proven ability to generate returns, India’s healthcare sector has become a prime target for private equity investment. As other regional markets struggle, India’s growth trajectory appears to be just beginning.
While the broader Asia-Pacific region experienced a significant downturn in buyout activity, with a nearly 49% decline, India managed to weather the storm with only an 18% decrease in healthcare private equity deals compared to 2023. Bain & Company’s report indicates that India has solidified its position as the dominant player in the region, capturing a substantial share of healthcare deal volume. Investors are recognizing that India’s health sector is not just holding steady; it is flourishing.
Key Factors Fueling the Growth
What factors are contributing to India’s robust performance in healthcare investments?
Strong Economic Growth: With a projected GDP growth rate of 7% in 2024, India’s economy is fostering a strong appetite for investment.
Successful Exits: The $1.6 billion sale of BSV Group to Mankind Pharma by Advent International exemplifies a successful exit, showcasing the potential for lucrative returns in the sector.
Rising Healthcare Spending: Forecasts suggest that healthcare expenditure will soar to $320 billion by 2028, signaling a lucrative opportunity for investors.
Investment Trends
In recent years, investor interest has concentrated on hospitals, clinics, and support services, with biopharma deals also gaining traction. However, healthcare providers healthcare providers have been the focal point of activity. The increasing demand for quality healthcare in India is driving a surge in deal-making, prompting private equity firms to actively seek investment opportunities.
Outlook
With a strong economic foundation and a proven ability to generate returns, India’s healthcare sector has become a prime target for private equity investment. As other regional markets struggle, India’s growth trajectory appears to be just beginning.
.jpg "Dr Suresh Raghavaiah: Bringing Global Expertise to Advance Transplant Surgery in India")
